Stem Cells
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


First published online August 24, 2006
Stem Cells Vol. 24 No. 11 November 2006, pp. 2355 -2366
doi:10.1634/stemcells.2005-0551; www.StemCells.com
© 2006 AlphaMed Press

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Supplemental Data
Right arrow All Versions of this Article:
2005-0551v1
24/11/2355    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Reprints/Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Zeng, L.
Right arrow Articles by Verfaillie, C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Zeng, L.
Right arrow Articles by Verfaillie, C.

TISSUE-SPECIFIC STEM CELLS

Multipotent Adult Progenitor Cells from Swine Bone Marrow

Lepeng Zenga,c, Eric Rahrmanna, Qingsong Hub, Troy Lunda, Lee Sandquista, Mike Feltena, Timothy D. O'Briend, Jianyi Zhangb,c, Catherine Verfailliea,b

aStem Cell Institute,
bDepartment of Medicine, Medical School,
cDepartment of Biomedical Engineering, and
dVeterinary Population Medicine Department, University of Minnesota, Minneapolis, Minnesota, USA

Key Words. Bone marrow • Cell therapy • Heart failure • Stem cell • Large animal model

Correspondence: Catherine Verfaillie, M.D., Professor of Medicine, Director, Stem Cell Institute, University of Minnesota, McGuire Translational Research Facility, 2001 6th St. SE, Mail Code 2873, Minneapolis, Minnesota 55455, USA. Telephone: 612-625-0602; Fax: 612-624-2436; e-mail: Catherine.Verfaillie{at}med.kuleuven.be

Received November 8, 2005; accepted for publication May 25, 2006.


We show that multipotent adult progenitor cells (MAPCs) can be derived from both postnatal and fetal swine bone marrow (BM). Although swine MAPC (swMAPC) cultures are initially mixed, cultures are phenotypically homogenous by 50 population doublings (PDs) and can be maintained as such for more than 100 PDs. swMAPCs are negative for CD44, CD45, and major histocompatibility complex (MHC) classes I and II; express octamer binding transcription factor 3a (Oct3a) mRNA and protein at levels close to those seen in human ESCs (hESCs); and have telomerase activity preventing telomere shortening even after 100 PDs. Using quantitative-reverse transcription-polymerase chain reaction (Q-RT-PCR), immunofluorescence, and functional assays, we demonstrate that swMAPCs differentiate into chondrocytes, adipocytes, osteoblasts, smooth muscle cells, endothelium, hepatocyte-like cells, and neuron-like cells. Consistent with what we have shown for human and rodent MAPCs, Q-RT-PCR demonstrated a significant upregulation of transcription factors and other lineage-specific transcripts in a time-dependent fashion similar to development. When swMAPCs were passaged for 3–6 passages at high density (2,000–8,000 cells per cm2), Oct3a mRNA levels were no longer detectable, cells acquired the phenotype of mesenchymal stem cells (CD44+, MHC class I+), and could differentiate into typical mesenchymal lineages (adipocytes, osteoblasts, and chondroblasts), but not endothelium, hepatocyte-like cells, or neuron-like cells. Even if cultures were subsequently replated at low density (approximately 100–500 cells per cm2) for >20 PDs, Oct3a was not re-expressed, nor were cells capable of differentiating to cells other than mesenchymal-type cells. This suggests that the phenotype and functional characteristics of swMAPCs may not be an in vitro culture phenomenon.




This article has been cited by other articles:


Home page
CirculationHome page
L. Zeng, Q. Hu, X. Wang, A. Mansoor, J. Lee, J. Feygin, G. Zhang, P. Suntharalingam, S. Boozer, A. Mhashilkar, et al.
Bioenergetic and Functional Consequences of Bone Marrow-Derived Multipotent Progenitor Cell Transplantation in Hearts With Postinfarction Left Ventricular Remodeling
Circulation, April 10, 2007; 115(14): 1866 - 1875.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
STEM CELLS THE ONCOLOGIST CME ALPHAMED PRESS JOURNALS
http://www.stemcellsportal.com/
Copyright © 2006 by AlphaMed Press.